Home/Filings/4/0000899243-22-036546
4//SEC Filing

Hammoud Tarek 4

Accession 0000899243-22-036546

CIK 0001868912other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 5:45 PM ET

Size

9.4 KB

Accession

0000899243-22-036546

Insider Transaction Report

Form 4
Period: 2022-11-17
Hammoud Tarek
Director10% Owner
Transactions
  • Conversion

    Common Units of Enfusion Ltd. LLC

    2022-11-171,870,3869,000,000 total(indirect: See Footnote)
    Class A Common Stock (1,870,386 underlying)
  • Conversion

    Class A Common Stock

    2022-11-17+1,870,3861,870,386 total(indirect: See footnote)
Transactions
  • Conversion

    Class A Common Stock

    2022-11-17+1,870,3861,870,386 total(indirect: See footnote)
  • Conversion

    Common Units of Enfusion Ltd. LLC

    2022-11-171,870,3869,000,000 total(indirect: See Footnote)
    Class A Common Stock (1,870,386 underlying)
Footnotes (2)
  • [F1]Common Units of Enfusion Ltd. LLC, and the corresponding shares of Class B common stock are exchangeable for shares of the issuer's Class A common stock on a one-for-one basis with the issuer having the ability to elect to pay cash in lieu of issuing Class A common stock.
  • [F2]These Common Units are held by LRA Ventures, LLC. Tarek Hammoud is the sole manager of LRA Ventures, LLC, an estate planning vehicle. Mr. Hammoud may be deemed to have dispositive power over the securities held by LRA Ventures, LLC. Mr. Hammoud disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Issuer

Enfusion, Inc.

CIK 0001868912

Entity typeother

Related Parties

1
  • filerCIK 0001880790

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:45 PM ET
Size
9.4 KB